Explore Products

Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases

  • AcceGen R&D Team
  • Jul 28, 2023
  • 24

You Might Also Like

AcceGen Scroll Top Button